Work package 6 has the following objectives:

1. Estimate costs and health benefits associated with the interventions, including estimation of quality of life impact of infections.

2. Perform cost-effectiveness evaluations accounting for heterogeneity based on the clinical trial results.

3. Perform cost-effectiveness evaluations beyond the trial duration incorporating the impact on resistance and its health and cost consequences in the long term.

4. Conduct budget-impact analyses to provide estimates of affordability of tested interventions in different resource settings.

5. Identify potential barriers and facilitators of implementation in two selected low-and-middle-income countries.

Leading Partner

UK Health Security Agency

Other Partners Involved

University of Oxford, Barcelona Institute for Global Health